PubRank

A J Weiss

Author PubWeight™ 23.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A 1998 4.76
2 Sexual adjustment, identification, and attitudes of patients with myelopathy. Arch Phys Med Rehabil 1966 1.50
3 Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. Int J Oncol 2000 1.05
4 Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab 2007 0.99
5 Varied appearance of AIDS-related lymphoma in the chest. Radiology 1989 0.94
6 Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity. Cancer 1977 0.89
7 Protection of mice against 7,12-dimethylbenz(a)anthracene-induced skin tumors by immunization with a fluorinated analog of the carcinogen. Cancer Res 1981 0.89
8 Management of brachial plexus tumors. Arch Otolaryngol 1977 0.87
9 A phase I study of emetine hydrochloride (NSC 33669) in solid tumors. Cancer 1973 0.86
10 Combination phase 1-II study of imidazole carboxamide (NCS45388). Oncology 1972 0.84
11 Phase II study of 5-azacytidine in solid tumors. Cancer Treat Rep 1977 0.84
12 Streptozotocin therapy in 22 cancer patients. Cancer 1975 0.83
13 Preliminary pharmacokinetics of streptozotocin, an antineoplastic antibiotic. J Clin Pharmacol 1977 0.83
14 Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. Cancer Treat Rep 1976 0.83
15 Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816). Cancer Chemother Rep 1974 0.82
16 Clinical studies with tubercidin administered after absorption into human erythrocytes. Cancer Res 1970 0.81
17 Absorption, distribution, and excretion of 5-azacytidine (NSC-102816) in man. Cancer Chemother Rep 1972 0.81
18 Preoperative embolization of retroperitoneal hemangiopericytomas as an aid in their removal. Cancer 1982 0.80
19 Intraarterial chemotherapy with limb-sparing resection of large soft-tissue sarcomas of the extremities. J Vasc Interv Radiol 1992 0.78
20 Soft-tissue complications of intra-arterial chemotherapy for extremity sarcomas. Ann Plast Surg 1998 0.77
21 Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256). Cancer Chemother Rep 1971 0.76
22 Hepatoma and hepatitis-associated antigen. Br Med J 1973 0.75
23 A phase I study of 6-azauridine (NSC-32074) in solid tumors. Cancer Chemother Rep 1969 0.75
24 Phase I study of L-asparaginase (NSC 109229). Oncology 1975 0.75
25 How to influence people outside your control. Superv Manage 1977 0.75
26 Phase II study of azotomycin (NSC-56654). Cancer Chemother Rep 1968 0.75
27 Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors. Oncology 1974 0.75
28 Surviving and succeeding in the "political" organization: overcoming organizational myopia. Superv Manage 1978 0.75
29 Reluctant patient. Special problems in psychologic treatment of patient with myelopathy. N Y State J Med 1968 0.75
30 Phase I study of a combination of azotomycin (NSC-56654) and 5-fluorouracil (NSC-19893) in malignant disease. Cancer Chemother Rep 1970 0.75
31 Evaluation of daunorubicin in adenocarcinoma of the large intestine. Cancer Treat Rep 1976 0.75
32 The unmotivated patient. Arch Phys Med Rehabil 1968 0.75
33 Phase I studies of porfiromycin (NSC--56410) in solid tumors. J Surg Oncol 1975 0.75
34 The absorption and metabolism of dibromodulcitol in patients with advanced cancer. Clin Pharmacol Ther 1972 0.75
35 Chemotherapy in ovarian malignancy: tumor sensitivity testing. Obstet Gynecol 1966 0.75
36 Fate of streptozotocin (NSC-85998)in patients with advanced cancer. Cancer Chemother Rep 1976 0.75
37 Analysis of procarbazine and metabolites by gas chromatography-mass spectrometry. J Chromatogr 1980 0.75
38 Surviving and succeeding in the "political" organization: becoming a leader. Superv Manage 1978 0.75
39 Murine studies with 5-fluorouracil and leucovorin. J Natl Cancer Inst 1989 0.75
40 Phase II study of carbestrol (NSC-19962) in patients with solid tumors. Cancer Chemother Rep 1972 0.75
41 Adult invasive subcutaneous hemangioma. Otolaryngology 1979 0.75
42 Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung. Cancer Chemother Rep 1971 0.75
43 An improved method for isolating Ca2+-resistant myocytes from the adult rat heart. Res Commun Chem Pathol Pharmacol 1988 0.75
44 Psychologic adjustment of patients with myelopathy. Arch Phys Med Rehabil 1966 0.75
45 Phase I study of dibromodulcitol (NSC-104800). Cancer Chemother Rep 1971 0.75
46 A hypothesis concerning the effect of changes in scheduling upon the cardiotoxicity of adriamycin. Oncology 1983 0.75
47 Extremity osteosarcomas: intraarterial chemotherapy and limb-sparing resection with 2-year follow-up. Radiology 1990 0.75
48 Illness guilt, inadequacy guilt and rehabilitation therapy. Psychoanal Rev 1968 0.75
49 Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors. Cancer Treat Rep 1978 0.75
50 Biliary sclerosis and the implanted pump. J Clin Oncol 1985 0.75
51 Phase II study of dibromodulcitol (NSC-104800). Cancer Chemother Rep 1975 0.75
52 Prevention of stenosis after vaginal reconstruction using interdigitating flaps of skin and mucosa. Ann Plast Surg 1987 0.75
53 A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2. Oncology 1975 0.75